DJ6ual - An Irish Girl

Search This Blog:



Comment FAQ...

When leaving a COMMENT above, if you have any trouble please try clearing your cache and refreshing the page. Thank you.

Multiple Sclerosis Drug will skyrocket Questcor Pharmaceuticals Inc. (QCOR) Stocks Monday

December 26, 2009

Among the sectors whose shares are expected to see active trade in Monday's are health-care and energy.

Cal-Maine Foods Inc. (CALM) on Monday expected to report earnings of 66 cents a share for its fiscal second quarter, according to analysts polled by Thomson Reuters.

Bunge Ltd. (BG) said it plans to acquire Usina Moema Participacoes, a Brazilian sugar-holding company, for about $452 million in stock and $480 million in assumed debt, in a deal by the agribusiness specialist to take its place in the ethanol market. Read more about the proposed deal.

Merrimac Industries Inc. (MRM) has agreed to be acquired by industrial manufacturer Crane Co. (CR) for about $52 million, or $16 a share.

Questcor Pharmaceuticals Inc. (QCOR) said the U.S. Food and Drug Administration accepted for review its supplemental new-drug application for H.P. Acthar to treat infantile spasms. The drug is currently cleared for marketing in the U.S. for multiple-sclerosis exacerbations, nephrotic syndrome and other disorders.

Heath-insurance stocks, including Aetna Inc. (AET) , Humana Inc. (HUM) and Tenet Healthcare Group (THC) will be in focus after the Senate on Thursday approved a sweeping White House-backed overhaul of the U.S. health-care system.

Natural-gas stocks including Chevron Corp. (CVX) will also be in focus as a major winter storm moved the Midwest and Plains states, and after slightly bearish inventory data. Read about energy stocks.

Source: MarketWatch

Go Back

alohaaloha.net



Comment